ArticlePoultry science2026
Effects of dietary supplementation with encapsulated capsaicinoids on growth performance and cecal microbiota in broiler chickens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Capsaicinoids (CAPs) are widely investigated as natural alternatives to antibiotic growth promoters; however, most studies have examined capsaicin (CAP) alone, and the combined effects of CAP and dihydrocapsaicin (DHC) in encapsulated form remain largely unexplored in broilers. This study evaluated dietary encapsulated capsaicinoids (E-CAPs; 0.47% CAP and 0.22% DHC w/w) on growth performance, meat quality, serum biochemistry, antioxidant status, organ indices, intestinal morphology, and gut microbiota in Arbor Acres broilers. A total of 384 broilers were randomly assigned to a basal diet (CON) or diets supplemented with 150 mg/kg (LDC) or 450 mg/kg (HDC) E-CAPs. Compared with CON, HDC increased average daily gain and reduced the feed-to-gain ratio during the grower and overall periods (P < 0.05), whereas LDC showed limited effects. HDC also decreased serum alanine aminotransferase and total bile acid levels relative to CON (P < 0.05), without differences in other biochemical or antioxidant parameters or in organ indices and intestinal morphology, indicating good metabolic safety. Both LDC and HDC reduced crude fat content and thiobarbituric acid reactive substances levels in breast meat during refrigerated storage, without affecting meat color, compared with the CON group (P < 0.05). Relative to CON, HDC reduced the relative abundance of Actinomycetota and increased the relative abundances of Clostridium_innocuum, Alistipes, and Turicimonas (q < 0.05), accompanied by predicted enrichment of pathways related to bacterial secretion systems and antimicrobial resistance. Overall, supplementation with 450 mg E-CAPs/kg diet (≈3.1 mg total CAPs/kg) enhanced growth performance, improved meat quality, and beneficially modulated gut microbiota while maintaining metabolic and intestinal health, supporting the combined encapsulated CAP - DHC formulation as a safe and effective feed additive for broilers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.